Julie C Will1, Keming Yuan2, Earl Ford2. 1. From the Division for Heart Disease and Stroke Prevention (J.C.W., K.Y.) and Division of Population Health (E.F.), Centers for Disease Control and Prevention, Atlanta, GA. jxw6@cdc.gov. 2. From the Division for Heart Disease and Stroke Prevention (J.C.W., K.Y.) and Division of Population Health (E.F.), Centers for Disease Control and Prevention, Atlanta, GA.
Abstract
BACKGROUND: The prevalence of angina from 1971 to 1994 was relatively flat for whites and blacks. We ask whether the prevalence and medical history of angina have changed during 1988 to 2012. METHODS AND RESULTS: We used the National Health and Nutrition Examination Survey data from 1988 to 2004 and the data from the six 2-year surveys from 2001 to 2012. We calculated trends in both crude and standardized prevalence rates for the Rose questionnaire on angina (symptomatology) and a question asking whether the respondent had ever been told by a medical professional that they had angina (medical history). In 2009 to 2012, there were on average 3.4 million (95% confidence interval, 2.8-4.0 million) people aged ≥40 years in the United States each year with angina (Rose questionnaire) and 4.5 million (95% confidence interval, 3.5-5.1 million) people with a medical history of angina. The burden of angina varied across age, race, and sex categories, and the pattern of variation differed by whether symptomatology or medical history was assessed. Statistically significant declines in the rates for both outcomes were noted, for the most part, in people aged ≥65 years. Age and sex standardized rates declined significantly for whites but not for blacks. CONCLUSIONS: Rates of angina symptoms and medical history of angina have declined among non-Hispanic whites and among adults aged ≥65 years. Blacks have not experienced these same declines. Clearly, additional study is required to understand these declines and to track the future cost and burden of angina in the US population.
BACKGROUND: The prevalence of angina from 1971 to 1994 was relatively flat for whites and blacks. We ask whether the prevalence and medical history of angina have changed during 1988 to 2012. METHODS AND RESULTS: We used the National Health and Nutrition Examination Survey data from 1988 to 2004 and the data from the six 2-year surveys from 2001 to 2012. We calculated trends in both crude and standardized prevalence rates for the Rose questionnaire on angina (symptomatology) and a question asking whether the respondent had ever been told by a medical professional that they had angina (medical history). In 2009 to 2012, there were on average 3.4 million (95% confidence interval, 2.8-4.0 million) people aged ≥40 years in the United States each year with angina (Rose questionnaire) and 4.5 million (95% confidence interval, 3.5-5.1 million) people with a medical history of angina. The burden of angina varied across age, race, and sex categories, and the pattern of variation differed by whether symptomatology or medical history was assessed. Statistically significant declines in the rates for both outcomes were noted, for the most part, in people aged ≥65 years. Age and sex standardized rates declined significantly for whites but not for blacks. CONCLUSIONS: Rates of angina symptoms and medical history of angina have declined among non-Hispanic whites and among adults aged ≥65 years. Blacks have not experienced these same declines. Clearly, additional study is required to understand these declines and to track the future cost and burden of angina in the US population.
Authors: Wayne D Rosamond; Lloyd E Chambless; Gerardo Heiss; Thomas H Mosley; Josef Coresh; Eric Whitsel; Lynne Wagenknecht; Hanyu Ni; Aaron R Folsom Journal: Circulation Date: 2012-03-15 Impact factor: 29.690
Authors: Robert W Yeh; Stephen Sidney; Malini Chandra; Michael Sorel; Joseph V Selby; Alan S Go Journal: N Engl J Med Date: 2010-06-10 Impact factor: 91.245
Authors: Emelia J Benjamin; Michael J Blaha; Stephanie E Chiuve; Mary Cushman; Sandeep R Das; Rajat Deo; Sarah D de Ferranti; James Floyd; Myriam Fornage; Cathleen Gillespie; Carmen R Isasi; Monik C Jiménez; Lori Chaffin Jordan; Suzanne E Judd; Daniel Lackland; Judith H Lichtman; Lynda Lisabeth; Simin Liu; Chris T Longenecker; Rachel H Mackey; Kunihiro Matsushita; Dariush Mozaffarian; Michael E Mussolino; Khurram Nasir; Robert W Neumar; Latha Palaniappan; Dilip K Pandey; Ravi R Thiagarajan; Mathew J Reeves; Matthew Ritchey; Carlos J Rodriguez; Gregory A Roth; Wayne D Rosamond; Comilla Sasson; Amytis Towfighi; Connie W Tsao; Melanie B Turner; Salim S Virani; Jenifer H Voeks; Joshua Z Willey; John T Wilkins; Jason Hy Wu; Heather M Alger; Sally S Wong; Paul Muntner Journal: Circulation Date: 2017-01-25 Impact factor: 29.690
Authors: I Akushevich; A P Yashkin; J Kravchenko; F Fang; K Arbeev; F Sloan; A I Yashin Journal: Theor Popul Biol Date: 2017-01-24 Impact factor: 1.570
Authors: Holli A DeVon; Glorieuse Uwizeye; Hui Yan Cai; Adhir R Shroff; Joan E Briller; Amer Ardati; Debra Hoppensteadt; Lauren Rountree; Judith M Schlaeger Journal: Acupunct Med Date: 2021-12-02 Impact factor: 2.267
Authors: Daniel M Blumenthal; Sidney E Howard; Jennifer Searl Como; Sandra M O'Keefe; Steven J Atlas; Daniel M Horn; Neil W Wagle; Jason H Wasfy; Robert W Yeh; Joshua P Metlay Journal: JAMA Netw Open Date: 2021-06-01
Authors: Elizabeth Y Liu; Mohammed E Al-Sofiani; Hsin-Chieh Yeh; Justin B Echouffo-Tcheugui; Joshua J Joseph; Rita R Kalyani Journal: JAMA Netw Open Date: 2021-06-01